Systemic Therapies May Increase Risk of VTE in Patients With Cancer and COVID-19
Researchers found a higher risk of VTE in patients with cancer and COVID-19 who were receiving systemic cancer therapies.
Source: oncologynurseadvisor.com
Stay updated with breaking news from Hsuc Y. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Researchers found a higher risk of VTE in patients with cancer and COVID-19 who were receiving systemic cancer therapies.